PURPOSE: Accurate preoperative radiological staging of hilar cholangiocarcinoma remains difficult, and a number of patients are found to have irresectable advanced tumours or occult metastases at exploration. Staging laparoscopy can improve the detection of irresectable disease, avoiding unnecessary laparotomy. This study examines the role of staging laparoscopy in hilar cholangiocarcinoma, with a focus on yield over different time periods and identification of preoperative factors increasing the risk of irresectable disease. METHODS: Retrospective case note review of all patients undergoing staging laparoscopy for radiologically resectable hilar cholangiocarcinoma, identified from the hepatobiliary multidisciplinary team database, was performed. RESULTS: One hundred consecutive patients underwent staging laparoscopy between 1998 and 2011. Of these, 34 patients were found to be irresectable due to metastatic disease, and 11, due to extensive local disease. Fifty patients proceeded to exploratory laparotomy following staging laparoscopy, and 36 % (18/50) of whom were found to have irresectable disease: 12 patients due to advanced local disease and 6 patients due to metastases. The overall yield of laparoscopy was 45 %, and the accuracy was 71 %. There was no significant difference in age, preoperative bilirubin, neutrophil/lymphocyte ratio, Ca19-9 levels or T stage between patients with resectable disease and with irresectable disease on laparoscopy. There was also no change in the yield of laparoscopy over time, despite advances in radiological imaging. CONCLUSION: In this series, staging laparoscopy avoided unnecessary laparotomy in 45 % of patients with radiologically resectable hilar cholangiocarcinoma. No factor was able to predict positive yield, and therefore, all patients with potentially resectable hilar cholangiocarcinoma should undergo staging laparoscopy.
PURPOSE: Accurate preoperative radiological staging of hilar cholangiocarcinoma remains difficult, and a number of patients are found to have irresectable advanced tumours or occult metastases at exploration. Staging laparoscopy can improve the detection of irresectable disease, avoiding unnecessary laparotomy. This study examines the role of staging laparoscopy in hilar cholangiocarcinoma, with a focus on yield over different time periods and identification of preoperative factors increasing the risk of irresectable disease. METHODS: Retrospective case note review of all patients undergoing staging laparoscopy for radiologically resectable hilar cholangiocarcinoma, identified from the hepatobiliary multidisciplinary team database, was performed. RESULTS: One hundred consecutive patients underwent staging laparoscopy between 1998 and 2011. Of these, 34 patients were found to be irresectable due to metastatic disease, and 11, due to extensive local disease. Fifty patients proceeded to exploratory laparotomy following staging laparoscopy, and 36 % (18/50) of whom were found to have irresectable disease: 12 patients due to advanced local disease and 6 patients due to metastases. The overall yield of laparoscopy was 45 %, and the accuracy was 71 %. There was no significant difference in age, preoperative bilirubin, neutrophil/lymphocyte ratio, Ca19-9 levels or T stage between patients with resectable disease and with irresectable disease on laparoscopy. There was also no change in the yield of laparoscopy over time, despite advances in radiological imaging. CONCLUSION: In this series, staging laparoscopy avoided unnecessary laparotomy in 45 % of patients with radiologically resectable hilar cholangiocarcinoma. No factor was able to predict positive yield, and therefore, all patients with potentially resectable hilar cholangiocarcinoma should undergo staging laparoscopy.
Authors: A Fritscher-Ravens; K H Bohuslavizki; D C Broering; L Jenicke; H Schäfer; R Buchert; X Rogiers; M Clausen Journal: Nucl Med Commun Date: 2001-12 Impact factor: 1.690
Authors: Saxon Connor; Emma Barron; Stephen J Wigmore; Krishnakumar K Madhavan; Rowan W Parks; O James Garden Journal: J Gastrointest Surg Date: 2005-04 Impact factor: 3.452
Authors: D Goere; G D Wagholikar; P Pessaux; N Carrère; A Sibert; V Vilgrain; A Sauvanet; J Belghiti Journal: Surg Endosc Date: 2006-02-27 Impact factor: 4.584
Authors: Anthony T Ruys; Roel J Bennink; Henderik L van Westreenen; Marc R Engelbrecht; Olivier R Busch; Dirk J Gouma; Thomas M van Gulik Journal: HPB (Oxford) Date: 2011-03-07 Impact factor: 3.647
Authors: Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik Journal: Langenbecks Arch Surg Date: 2014-06-25 Impact factor: 3.445
Authors: Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik Journal: Hepatobiliary Surg Nutr Date: 2014-02 Impact factor: 7.293
Authors: Jan Nilsson; Sam Eriksson; Peter Nørgaard Larsen; Inger Keussen; Susanne Christiansen Frevert; Gert Lindell; Christian Sturesson Journal: Acta Radiol Open Date: 2015-05-15
Authors: Robert J S Coelen; Anthony T Ruys; Marc G H Besselink; Olivier R C Busch; Thomas M van Gulik Journal: Surg Endosc Date: 2016-02-19 Impact factor: 4.584
Authors: Prabhu Arumugam; Vickna Balarajah; Jennifer Watt; Ajit T Abraham; Satyajit Bhattacharya; Hemant M Kocher Journal: Indian J Med Res Date: 2016-04 Impact factor: 2.375